News

Survey says foot health not top-of-mind

BY Michael Johnsen

According to a survey released earlier this year by the American Podiatric Medical Association, foot health ranks near the bottom on the list of body parts/functions that Americans make a concentrated effort to “take care of.” Only 2-in-10 Americans think about their foot health regularly, and this number has remained consistent since 2010, according to the APMA. And yet, almost 8-in-10 Americans have experienced a foot problem, and half say it has impacted their quality of life. Those with regular foot pain tend to have a host of other health issues.

(For the full report, including charts, click here.)

Overall, sales of foot care products were relatively flat for the 52 weeks ended July 13, down 0.6% to $1 billion. The lion’s share of the foot care product sales volume originates from devices, which were down 1.8% to $661.8 million.

However, that may change with the number of devices targeting consumers with plantar fasciitis coming to market. Plantar fasciitis is a condition that impacts 2 million people at any one time, according to the American Academy of Orthopedic Surgeons. Some people are more prone to plantar fasciitis, say orthopedic foot and ankle doctors, including women, people who are overweight and workers who spend a lot of time walking or standing on hard surfaces. People with very flat feet or very high arches also are more prone to plantar fasciitis.

Implus identified the niche need within foot care a year ago with its launch of the Airplus Plantar Fasciitis Orthotic, which provides support for the plantar fascia and a gel cushion to help relieve heel pain. Merck’s Dr. Scholl’s brand has a line of products called PRO Pain Relief Orthotics that targets sufferers of plantar fasciitis, and Mueller recently launched FasciaDerm PFTape to help relieve heel and/or arch pain.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

TyraTech says ‘Vamousse’ to lice

BY Michael Johnsen

MELBOURNE, Fla. — TyraTech’s new non-pesticide homeopathic head lice treatment Vamousse will safely kill 100% of head lice and nits within 15 minutes of application, according to the company.

(For the full report, including charts, click here.)

The company also is introducing a daily shampoo application to prevent lice infestation, or re-infestation. The mousse will retail for a suggested $24.99, while the preventive shampoo will retail for a suggested $19.99.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Hyland’s tackles babies’ ‘unmet needs’

BY Michael Johnsen

LOS ANGELES — Hyland’s launched Hyland’s Baby Nighttime teething tablets, a nighttime version to join its best-selling infant oral pain reliever Hyland’s Baby teething tablets in the $40 million infant oral pain segment.

(For the full report, including charts, click here.)

The new product contains no benzocaine or melatonin. Hyland’s also introduced Hyland’s Baby Calming tTablets, citing an unmet need for a natural infant product for fussiness and occasional sleeplessness. According to Hyland’s, moms are 32% more likely to give their child a calming product if it is natural.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?